Galenica AG
Galenica AG (GALNF) Revenue
Annual & quarterly revenue history · segment & region breakdown
GALNF · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsGalenica AG trailing twelve-month (TTM) revenue is $8.07B, an increase of 5.52% year-over-year from $4.14B in FY2025.
Revenue trend
2025 – 2014 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $4.14B | +$0.22B | +5.52% |
| 2024-12-31 | $3.92B | +$0.18B | +4.67% |
| 2023-12-31 | $3.75B | -$0.27B | -6.68% |
| 2022-12-31 | $4.01B | +$0.18B | +4.69% |
| 2021-12-31 | $3.83B | +$0.35B | +10.20% |
| 2020-12-31 | $3.48B | +$0.17B | +5.25% |
| 2019-12-31 | $3.31B | +$0.13B | +4.25% |
| 2018-12-31 | $3.17B | +$0.03B | +0.82% |
| 2017-12-31 | $3.15B | +$0.14B | +4.54% |
| 2016-12-31 | $3.01B | +$0.09B | +3.22% |
Compare revenue vs peers
Medical - DistributionCompare GALNF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Galenica AG receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Galenica AG reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in CHF.
Data sourced from Galenica AG's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
GALNF revenue · 4 questionsGALNF's trailing twelve-month (TTM) revenue is $8.07B. That is an increase of 5.52% year-over-year from $4.14B in FY2025.
▸ Source: FMP · Galenica AG SEC filings · GAAP · Galenica AG SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026